Trazodone is not an SSRI. It belongs to a different drug class called SARIs, which stands for serotonin antagonist and reuptake inhibitors. The confusion is understandable because both trazodone and SSRIs affect serotonin, and trazodone is sometimes loosely called a “serotonin uptake inhibitor.” But the way it works in the brain is fundamentally different from SSRIs like fluoxetine (Prozac) or sertraline (Zoloft).
How Trazodone Differs From SSRIs
The distinction comes down to what each drug primarily does with serotonin. SSRIs work by blocking the reabsorption of serotonin, keeping more of it available in the spaces between nerve cells. That reuptake inhibition is their main and most potent effect.
Trazodone does something more complex. Its strongest pharmacological action is blocking specific serotonin receptors (called 5-HT2 receptors) rather than preventing serotonin reuptake. It does inhibit serotonin reuptake to some degree, but that’s a secondary effect, not its primary one. A 1992 comparison published in PubMed put it plainly: trazodone likely works as an antidepressant through receptor blocking, while fluoxetine works through reuptake inhibition. Same neurotransmitter, different strategies.
This is why the “selective” in SSRI doesn’t apply to trazodone. SSRIs selectively target the serotonin reuptake pump. Trazodone hits multiple targets at once: serotonin receptors, histamine receptors, and certain adrenaline receptors. That broader activity profile gives it a very different set of effects, especially sedation.
Why Trazodone Is Classified as a SARI
The SARI class name captures both things trazodone does: it’s a serotonin antagonist (it blocks serotonin receptors) and a reuptake inhibitor (it modestly prevents serotonin from being reabsorbed). Other drugs in this small class include etoperidone and lorpiprazole, though trazodone is by far the most widely prescribed.
Despite being in a different class, trazodone performs comparably to SSRIs, tricyclic antidepressants, and SNRIs for treating major depression in clinical studies. The classification difference isn’t about effectiveness. It’s about how the drug achieves its results.
The Dose Changes What Trazodone Does
One of the more interesting things about trazodone is that it behaves almost like two different medications depending on the dose. At low doses, typically 25 to 100 mg, trazodone primarily blocks histamine and serotonin receptors, which produces a strong sedative effect. This is why it’s so commonly prescribed as a sleep aid, even though insomnia isn’t its FDA-approved use.
At higher doses, 150 to 600 mg, trazodone’s serotonin reuptake inhibition kicks in alongside the receptor blocking. That combination is what produces its antidepressant effect. So the person taking 50 mg of trazodone at bedtime for sleep is getting a pharmacologically different experience than someone taking 300 mg daily for depression.
Side Effects Compared to SSRIs
Because trazodone hits different receptors than SSRIs, its side effect profile looks different too. The most obvious difference is sedation. Trazodone causes significant drowsiness, which is a feature when prescribed for sleep but a drawback for daytime use. SSRIs are generally not sedating and can sometimes cause the opposite problem, making it harder to sleep.
SSRIs are well known for causing sexual side effects like reduced desire and difficulty with orgasm. Trazodone is less likely to cause those particular problems. However, it carries a rare but notable risk for men: prolonged erections. Priapism, a persistent painful erection requiring medical attention, occurs in fewer than 1% of patients. One study estimated the rate at roughly 1 in 1,000 to 1 in 10,000 male patients. In a cohort of 229 men taking trazodone, about 8% experienced some degree of prolonged erection, though none required emergency treatment.
Trazodone can also cause dizziness when standing up quickly due to its effects on adrenaline receptors. This is uncommon with SSRIs.
How Trazodone Moves Through Your Body
Trazodone reaches its peak blood levels quickly, about one hour on an empty stomach or two hours if taken with food. Its elimination half-life, the time it takes for half the drug to leave your system, ranges from about 5 to 13 hours depending on the individual and the study. This relatively short duration is one reason it works well as a bedtime sleep aid: it’s active long enough to help you sleep through the night but clears fairly quickly.
By comparison, many SSRIs have much longer half-lives. Fluoxetine, for instance, stays in the body for days. This difference matters if you miss a dose or stop the medication. Trazodone leaves your system faster, which means its effects wear off sooner but also means withdrawal symptoms can emerge more quickly if you stop abruptly after long-term use.
Why the Confusion Exists
Trazodone gets lumped in with SSRIs for a few practical reasons. Pharmacies and medical records sometimes categorize it broadly as an “antidepressant” without specifying the subclass. It’s often prescribed alongside or as an alternative to SSRIs. And because both drug types involve serotonin, the distinction can blur in casual conversation. But pharmacologically, calling trazodone an SSRI is inaccurate. It’s a SARI: a drug that blocks serotonin receptors first and inhibits reuptake second, with a side effect profile and dose-dependent behavior that reflect that different mechanism.